Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Teriflunomide price, strengths & recalls

Pharmacies pay $9.13 for 30 tablets of Teriflunomide 7 mg tablet this week, and from $6.70 to $9.13 across its 2 priced strengths and forms. 7 manufacturers make it. 1 recall is ongoing. Its official label last changed on April 9, 2026.

1 open recallGeneric
Pharmacies pay$9.13for 30 tablets of 7 mg tablet+4.3% in 4 weeks
Fair cash price
$21.00
Strengths
2
Makers
7
Updated
Nov 11

Teriflunomide price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
7 mg tablet$0.3044$9.13 / 30 tablets+4.3%-43.8%
14 mg tablet$0.2234$6.70 / 30 tablets-4.3%-69.8%

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
1 ongoing recall1 recall on record, latest Apr 16, 2025

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for teriflunomide? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedApril 9, 2026
Version7 of 6
EffectiveApr 1, 2026
Read the label

These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS. TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012

This drug has a boxed warning

WARNING: HEPATOTOXICITY and EMBRYOFETAL TOXICITY

• Hepatotoxicity

Clinically significant and potentially life-threatening liver injury, including acute liver failure requiring transplant, has been reported in patients treated with teriflunomide in the postmarketing setting [see Warnings and Precautions (5.1)]. Concomitant use of teriflunomide with other hepatotoxic drugs may increase the risk of severe liver injury.

Obtain transaminase and bilirubin levels within 6 months before initiation of teriflunomide therapy. Monitor ALT levels at least monthly for six months after starting teriflunomide [see Warnings and Precautions (5.1)]. If drug induced liver injury is suspected, discontinue teriflunomide and start an accelerated elimination procedure with cholestyramine or charcoal [see Warnings and Precautions (5.3)]. Teriflunomide is contraindicated in patients with severe hepatic impairment [see Contraindications (4)]. Patients with pre-existing liver disease may be at increased risk of developing elevated serum transaminases when taking teriflunomide.

• Embryofetal Toxicity

Teriflunomide is contraindicated for use in pregnant women and in females of reproductive potential who are not using effective contraception because of the potential for fetal harm. Teratogenicity and embryolethality occurred in animals at plasma teriflunomide exposures lower than that in humans. Exclude pregnancy before the start of treatment with teriflunomide in females of reproductive potential. Advise females of reproductive potential to use effective contraception during teriflunomide treatment and during an accelerated drug elimination procedure after teriflunomide treatment. Stop teriflunomide and use an accelerated drug elimination procedure if the patient becomes pregnant [see Contraindications (4), Warnings and Precautions (5.2, 5.3), Use in Specific Populations (8.1, 8.3), and Clinical Pharmacology (12.3)].

WARNING: HEPATOTOXICITY and EMBRYOFETAL TOXICITY

See full prescribing information for complete boxed warning.

• Hepatotoxicity

Clinically significant and potentially life-threatening liver injury, including acute liver failure requiring transplant, has been reported in patients treated with teriflunomide in the postmarketing setting (5.1). Concomitant use of teriflunomide with other hepatotoxic drugs may increase the risk of severe liver injury. Obtain transaminase and bilirubin levels within 6 months before initiation of teriflunomide and monitor ALT levels at least monthly for six months (5.1). If drug induced liver injury is suspected, discontinue teriflunomide and start accelerated elimination procedure (5.3).

• Embryofetal Toxicity

Teratogenicity and embryolethality occurred in animals administered teriflunomide (5.2, 8.1). Exclude pregnancy prior to initiating teriflunomide therapy (4, 5.2, 8.1, 8.3). Advise use of effective contraception in females of reproductive potential during treatment and during an accelerated drug elimination procedure (4, 5.2, 5.3, 8.1, 8.3). Stop teriflunomide and use an accelerated drug elimination procedure if the patient becomes pregnant (5.2, 5.3, 8.1).

Recent major changes (as listed on the label)

Warnings and Precautions (5.8) 2/2026

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
7 approved generic applications on the market

Teriflunomide questions

How much does teriflunomide cost without insurance?

Pharmacies pay about $9.13 for 30 tablets of teriflunomide 7 mg tablet ($0.3044 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $21.00. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is teriflunomide in shortage?

No shortage is reported for teriflunomide right now. We check the national shortage list every day.

Has teriflunomide been recalled?

1 recall on record, 1 ongoing. Recalls name specific lots - check yours.

When did the teriflunomide label last change?

The official label was last updated on April 9, 2026 (version 7). See what changed.

Talk about teriflunomide

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.